106 related articles for article (PubMed ID: 17490732)
1. Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer.
Simon I; Liu Y; Krall KL; Urban N; Wolfert RL; Kim NW; McIntosh MW
Gynecol Oncol; 2007 Jul; 106(1):112-8. PubMed ID: 17490732
[TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer early detection by circulating CA125 in the context of anti-CA125 autoantibody levels: Results from the EPIC cohort.
Fortner RT; Schock H; Le Cornet C; Hüsing A; Vitonis AF; Johnson TS; Fichorova RN; Fashemi T; Yamamoto HS; Tjønneland A; Hansen L; Overvad K; Boutron-Ruault MC; Kvaskoff M; Severi G; Boeing H; Trichopoulou A; Papatesta EM; La Vecchia C; Palli D; Sieri S; Tumino R; Sacerdote C; Mattiello A; Onland-Moret NC; Peeters PH; Bueno-de-Mesquita HBA; Weiderpass E; Quirós JR; Duell EJ; Sánchez MJ; Navarro C; Ardanaz E; Larrañaga N; Nodin B; Jirström K; Idahl A; Lundin E; Khaw KT; Travis RC; Gunter M; Johansson M; Dossus L; Merritt MA; Riboli E; Terry KL; Cramer DW; Kaaks R
Int J Cancer; 2018 Apr; 142(7):1355-1360. PubMed ID: 29159934
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer.
Mukama T; Fortner RT; Katzke V; Hynes LC; Petrera A; Hauck SM; Johnson T; Schulze M; Schiborn C; Rostgaard-Hansen AL; Tjønneland A; Overvad K; Pérez MJS; Crous-Bou M; Chirlaque MD; Amiano P; Ardanaz E; Watts EL; Travis RC; Sacerdote C; Grioni S; Masala G; Signoriello S; Tumino R; Gram IT; Sandanger TM; Sartor H; Lundin E; Idahl A; Heath AK; Dossus L; Weiderpass E; Kaaks R
Br J Cancer; 2022 May; 126(9):1301-1309. PubMed ID: 35031764
[TBL] [Abstract][Full Text] [Related]
4. A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort.
Terry KL; Schock H; Fortner RT; Hüsing A; Fichorova RN; Yamamoto HS; Vitonis AF; Johnson T; Overvad K; Tjønneland A; Boutron-Ruault MC; Mesrine S; Severi G; Dossus L; Rinaldi S; Boeing H; Benetou V; Lagiou P; Trichopoulou A; Krogh V; Kuhn E; Panico S; Bueno-de-Mesquita HB; Onland-Moret NC; Peeters PH; Gram IT; Weiderpass E; Duell EJ; Sanchez MJ; Ardanaz E; Etxezarreta N; Navarro C; Idahl A; Lundin E; Jirström K; Manjer J; Wareham NJ; Khaw KT; Byrne KS; Travis RC; Gunter MJ; Merritt MA; Riboli E; Cramer DW; Kaaks R
Clin Cancer Res; 2016 Sep; 22(18):4664-75. PubMed ID: 27060155
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation.
Kaaks R; Fortner RT; Hüsing A; Barrdahl M; Hopper M; Johnson T; Tjønneland A; Hansen L; Overvad K; Fournier A; Boutron-Ruault MC; Kvaskoff M; Dossus L; Johansson M; Boeing H; Trichopoulou A; Benetou V; La Vecchia C; Sieri S; Mattiello A; Palli D; Tumino R; Matullo G; Onland-Moret NC; Gram IT; Weiderpass E; Sánchez MJ; Navarro Sanchez C; Duell EJ; Ardanaz E; Larranaga N; Lundin E; Idahl A; Jirström K; Nodin B; Travis RC; Riboli E; Merritt M; Aune D; Terry K; Cramer DW; Anderson KS
Int J Cancer; 2018 Aug; 143(3):515-526. PubMed ID: 29473162
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers and Strategies for Early Detection of Ovarian Cancer.
Bast RC; Lu Z; Han CY; Lu KH; Anderson KS; Drescher CW; Skates SJ
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2504-2512. PubMed ID: 33051337
[TBL] [Abstract][Full Text] [Related]
7. Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis.
Kozak KR; Amneus MW; Pusey SM; Su F; Luong MN; Luong SA; Reddy ST; Farias-Eisner R
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12343-8. PubMed ID: 14523236
[TBL] [Abstract][Full Text] [Related]
8. Effects of blood collection conditions on ovarian cancer serum markers.
Thorpe JD; Duan X; Forrest R; Lowe K; Brown L; Segal E; Nelson B; Anderson GL; McIntosh M; Urban N
PLoS One; 2007 Dec; 2(12):e1281. PubMed ID: 18060075
[TBL] [Abstract][Full Text] [Related]
9. Antibody-Drug Conjugates: Advancing from Magic Bullet to Biological Missile.
Veneziani AC; Sneha S; Oza AM
Clin Cancer Res; 2024 Apr; 30(8):1434-1437. PubMed ID: 38306232
[TBL] [Abstract][Full Text] [Related]
10. Early detection of ovarian cancer.
Das PM; Bast RC
Biomark Med; 2008 Jun; 2(3):291-303. PubMed ID: 20477415
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two multiplexed technologies for profiling >1,000 serum proteins that may associate with tumor burden.
Ren A; Prassas I; Sugumar V; Soosaipillai A; Bernardini M; Diamandis EP; Kulasingam V
F1000Res; 2021; 10():509. PubMed ID: 34868557
[No Abstract] [Full Text] [Related]
12. Enigma of Ovarian Cancer - Early detection Challenges and Solutions!
Pradeep Y
J Midlife Health; 2024; 15(1):3-4. PubMed ID: 38764930
[No Abstract] [Full Text] [Related]
13. The biological functions and related signaling pathways of SPON2.
Zhang J; Liu G; Liu Y; Yang P; Xie J; Wei X
Front Oncol; 2023; 13():1323744. PubMed ID: 38264743
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of the oncogenic and immunological role of SPON2 in human tumors.
Tang J; Huang Q; Li X; Gu S
Medicine (Baltimore); 2023 Sep; 102(37):e35122. PubMed ID: 37713832
[TBL] [Abstract][Full Text] [Related]
15. PARG suppresses tumorigenesis and downregulates genes controlling angiogenesis, inflammatory response, and immune cell recruitment.
Johnson S; Karpova Y; Guo D; Ghatak A; Markov DA; Tulin AV
BMC Cancer; 2022 May; 22(1):557. PubMed ID: 35585513
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC.
Huang C; Ou R; Chen X; Zhang Y; Li J; Liang Y; Zhu X; Liu L; Li M; Lin D; Qiu J; Liu G; Zhang L; Wu Y; Tang H; Liu Y; Liang L; Ding Y; Liao W
J Exp Clin Cancer Res; 2021 Sep; 40(1):304. PubMed ID: 34583750
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated Fibroblast-derived Spondin-2 Promotes Motility of Gastric Cancer Cells.
Kuramitsu S; Masuda T; Hu Q; Tobo T; Yashiro M; Fujii A; Kitagawa A; Abe T; Otsu H; Ito S; Oki E; Mori M; Mimori K
Cancer Genomics Proteomics; 2021; 18(4):521-529. PubMed ID: 34183385
[TBL] [Abstract][Full Text] [Related]
18. MINDIN Exerts Protumorigenic Actions on Primary Prostate Tumors via Downregulation of the Scaffold Protein NHERF-1.
Álvarez-Carrión L; Gutiérrez-Rojas I; Rodríguez-Ramos MR; Ardura JA; Alonso V
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33498862
[TBL] [Abstract][Full Text] [Related]
19. Knockout of
Zhu W; Liu C; Lu T; Zhang Y; Zhang S; Chen Q; Deng N
Front Oncol; 2020; 10():1451. PubMed ID: 32983976
[TBL] [Abstract][Full Text] [Related]
20. Mindin serves as a tumour suppressor gene during colon cancer progression through MAPK/ERK signalling pathway in mice.
Cheng XS; Huo YN; Fan YY; Xiao CX; Ouyang XM; Liang LY; Lin Y; Wu JF; Ren JL; Guleng B
J Cell Mol Med; 2020 Aug; 24(15):8391-8404. PubMed ID: 32614521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
